Products

What will AGI do for Adrenalone?

This classification denotes an adrenergic agent with the molecular formula C9H11NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EGU41QL329, chemically known as 3,4-dihydroxy-alpha-methylaminoacetophenone but generally known as adrenalone, which bears US NIH Compound Identifier 7436. Adrenalone comes in forms base and hydrochloride. European Medicines Agency schedules Adrenalone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05279MIG. The term ADRENALONE is an International Non-Proprietary Name. World Health Organization schedules adrenalone in its Anatomical Therapeutic Chemical (ATC) Classification. ADRENALONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule adrenalone under HS 29225000 and SITC 51467. As of Q4 2014, ADRENALONE remains the US FDA Preferred Term for this commodity. Adrenalone bears US NLM identifiers UMLS ID C0050876 and NCI Concept Code C81339. SMILES: O=C(C1CC(O)C(O)CC1)CNC.

How AGI delivers it

Four ways AGI delivers for Adrenalone

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Adrenalone, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Adrenalone, get the professional outcome delivered as software, priced on results, not headcount.